The characteristics of blood glucose and WBC counts in peripheral blood of cases of hand foot and mouth disease in China: A systematic review

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Li, Yuyun ^a   Zhu, Runan ^a   Qian, Yuan ^a   Deng, Jie ^a  

^a CAPITAL INSTITUTE OF PEDIATRICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

AUTONOMIC NEUROPATHY; CENTRAL NERVOUS SYSTEM DISEASE; CHINA; DISEASE SEVERITY; ENTEROVIRUS 71; GLUCOSE BLOOD LEVEL; HAND FOOT AND MOUTH DISEASE; HUMAN; HYPERGLYCEMIA; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG EDEMA; META ANALYSIS (TOPIC); PREVALENCE; QUANTITATIVE ANALYSIS; REVIEW; SYSTEMATIC REVIEW (TOPIC); TAIWAN; BLOOD; FEMALE; MALE; META ANALYSIS; METABOLISM; PATHOLOGY; REGRESSION ANALYSIS;

BLOOD GLUCOSE; CHINA; FEMALE; HAND, FOOT AND MOUTH DISEASE; HUMANS; LEUKOCYTE COUNT; MALE; REGRESSION ANALYSIS;

EID: 84855326556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029003     Document Type: Review

References (63)

1. Lin TY, Twu SJ, Ho MS, Chang LY, Lee CY, (2003) Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis 9: 291-293.
2. Li L, He Y, Yang H, Zhu J, Xu X, et al. (2005) Genetic Characteristics of Human Enterovirus 71 and Coxsackievirus A16 Circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol 43 (8): 3835-3839.
3. Podin Y, Gias EL, Ong F, Leong YW, Yee SF, et al. (2006) Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health 6: 180.
4. World Health Organization (2011) A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth Disease (HFMD). World Health Organization Regional Office for the Western Pacific and the Regional Emerging Diseases Intervention (REDI) Centre pp. 4-10, 38, 53-60.
5. Mao GS, Luo L, Liu XL, Wang LC, Liu LF, et al. (2008) The comparison between mild cases and severe cases of hand-foot-mouth disease. Chin J Infect Dis 26 (7): 387-390.
6. Yu LX, Zhe LL, Liu WD, (2011) The pre-albumin and blood glucose in serum of severe cases of hand foot and mouth disease and its significance. Chin Pediatr Emerg Med 18 (1): 57-58.
7. th Biochemistry Beijing People's Medical Publishing House, 102 p.
8. th Diagnostics Beijing People's Medical Publishing House, 241 p.
9. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (4): 719-748.
10. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7 (3): 177-188.
11. Higgins JP, Thompson S, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
12. Wei XL, (2010) The clinical significance of blood glucose, White Blood Cells counts and plasma ha-CRP in Hand Foot and Mouth Disease patients. Shandong Med J 50 (11): 70-71.
13. Li Q, Pan JH, He JY, Xu YH, Wang XG, (2010) The clinical significance of blood glucose in the assessment of Hand Foot and Mouth Disease patients with herpangia. Anhui Med J 31 (12): 1410-1411.
14. Luo LP, Gao YX, (2010) The clinical significance of the level of blood glucose in Hand Foot and Mouth Disease. J North China Coal Medical University 12 (3): 356.
15. Cui LD, Cheng YB, Song CL, Jin ZP, (2011) The clinical significance of white blood cells and glucose on hand, foot and mouth disease. China Prac Med 6 (2): 50-51.
16. Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, et al. (2002) Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Peadiatr 91: 632-635.
17. Liu X, Xia P, Feng X, Liang XB, Yu HK, et al. (2010) Neurogenic cardiac dysfunction in children with EV-71 hand-foot-and-mouth disease by real-time three-dimensional echocardiography. Chin J Med Ultrasound (Electronic Edition) 7 (11): 1844-1852.
18. Huang S, Han MF, Li XY, (2008) The clinical significance of blood glucose in Hand Foot and Mouth Disease patients. Anhui Med J 29 (4): 361-362.
19. Fan XC, Du PF, (2009) The analysis of significance in blood glucose monitoring for children with hand-foot-and-mouth disease. Anhui Med J 30 (3): 253-255.
20. Yang T, (2010) The application of blood glucose assay to hand foot and mouth disease. Acta Medcinae Sinica 23 (1): 68-70.
21. Jiang J, Guo SH, Ding DS, (2010) Effective measures used to stop mild cases progressing into serious cases of Hand Foot and Mouth Disease. J Qilu Nursing 16 (21): 119-121.
22. Li SH, Chen J, Wang HJ, Chen JY, Xu ZW, et al. (2010) Clinical and laboratory features of severe cases of hand, foot and mouth diseases in Wenzhou. Chin J Clin Infect Dis 3 (6): 337-339.
23. Zhang JH, (2010) Clinical features and etiology analysis of severe cases of hand-foot-mouth disease. Chinese and foreign medical research 8 (25): 12-14.
24. Liu J, (2009) The clinical characteristics of serious cases of Hand Foot and Mouth Disease and its therapy. Anhui Med J 30 (3): 261-262.
25. Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, et al. (1999) Clinical features and risk factors of pulmonary edema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354: 1682-1686.
26. Zhang GH, Lv X, Chen GH, Gao HY, Liao WQ, et al. (2010) The analysis of blood lactic acid and glucose in 45 serious cases of Hand Foot and Mouth Disease. China Clin Prac Med 4 (8): 132-133.
27. Zhou DM, Shen L, Zong WH, Jiang JJ, Huang ZX, (2010) The clinical features of hand-foot-mouth disease complicated with nervous system damage and the analysis for its risk factors. J Chongqing Medical University 34 (11): 1724-1726.
28. Wang HC, (2010) The clinical analysis of White Blood Cells counts in peripheral blood of Hand Foot and Mouth Disease patients. China Clin Prac Med 4 (8): 155-156.
29. Chen JH, Yan ZW, Li Q, Li SH, Gao HY, et al. (2010) Early clinical features and treatment of severe Hand-foot-mouth Disease. Acta Academiae Medicinae Weifang 32 (5): 363-365.
30. Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY, (2003) Proinflammatory Cytokine Reactions in Enterovirus 71 Infections of the Central Nervous System. CID 36: 269-274.
31. Li CC, Yang MY, Chen RF, Lin TY, Tsao KC, et al. (2002) Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in Southern Taiwan. Scand J Infect Dis 34: 104-109.
32. Zheng NH, (2011) The clinical analysis of 70 severe cases of hand foot and mouth disease. China Modern Doctor 49 (12): 126-127.
33. Qian N, Cheng ZB, (2010) Clinical characteristics and etiological study of infant Hand Foot and Mouth Disease caused by enterovirus 71 in Qingdao City in 2009. A master' degree thesis, Qingdao University pp. 17.
34. Liu YX, Xie JJ, He YX, Liu WL, Zhang MX, et al. (2008) Study of the clinical and laboratory features of hand-foot-mouth disease. Chinese J Exp Clin Virol 22 (6): 475-477.
35. Mai LL, Wen ZH, Du H, Tan W, (2011) Clinical analysis of 52 children with hand-foot-mouth disease. Chinese Journal of New Clinical Medicine 4 (4): 356-358.
36. Yue BZ, Zhang CL, Liu LP, Wu CL, (2010) Diagnosis and Treatment in Groups of 239 HFMD Cases. Chinese General Practice 13 (78): 2239-2241.
37. Yan ZW, Chen JH, Li SH, Gao HY, Wang WP, et al. (2011) Early clinical features of severe cases with hand-foot-mouth disease. Chin J Gen Pract 10 (5): 343-345.
38. Dai W, Feng ZZ, Yi SN, (2011) The comparison of clinical characteristics of hand foot and mouth disease between mild cases and severe cases. Chinese Community Doctors 13 (273): 88.
39. Tang LP, Tian X, Lin WJ, Wei HY, (2009) The significance of blood regular checkup, blood glucose and chest x-ray for hand foot and mouth disease. Chin J M isdiagn 9 (28): 6840-6841.
40. Shen Q, Hu AR, Shi KS, Li HS, (2011) The risk factors and clinical characteristics of severe cases of hand foot and mouth disease. Journal of Medical Research 40 (2): 93-95.
41. Mao YY, Yao JH, Cao LF, Wang JL, Chen LH, et al. (2009) Analysis of the treatment response and prognosis of severe hand-foot-mouth disease. Chin J Infect Dis 27 (1): 35-38.
42. Wang SM, Lei HY, Huang KJ, Wu JM, Wang JP, et al. (2003) Pathogenesis of Enterovirus 71 Brainstem Encephalitis in Pediatric Patients: Roles of Cytokines and Cellular Immune Activation in Patients with Pulmonary Edema. JID 188: 564-570.
43. Li SH, Wang HJ, Chen YP, Di JB, Chen JY, et al. (2010) Clinical analysis on 39 HFMD patients complicated with encephalitis. Chin Peciatr Emerg Med 17 (1): 49-51.
44. Li YF, Sun SX, Li ZF, Wu XF, Xu LY, (2010) Clinical features of hand-foot-mouth disease caused by enterovirus 71. J Clin Pediatr 28 (11): 1011-1014.
45. Liao Y, Xie HE, (2010) The detection of pathogen and clinical characteristics of Hand Foot and Mouth Disease. Jilin Medical Journal pp. 4075-4076.
46. Li JM, Xie JJ, He YX, Hu YW, Ao FJ, et al. (2009) Clinical features and high-risk factors of central nervous system complications in the patients with hand foot and mouth disease. Chin Pediatr Emerg Med 16 (2): 142-144.
47. Zhao HX, Zhang YL, Zhang Y, Deng J, Zhu RN, et al. (2008) Etiology and clinical characteristics of the 2007 outbreak of hand-foot-mouth disease in children in Beijing. J Clin Pediatr 26 (6): 467-469.
48. Zhang SB, Liao H, Huang CH, Tan QY, Zhang WL, et al. (2008) Serum types of enterovirus and clinical characteristics of 237 children with hand, foot and mouth disease in Shenzhen. Chin J Contemp Pediatr 10 (1): 38-41.
49. Abubakar S, Chee HY, Shafee N, Chua KB, Lam SK, (1999) Molecular detection of enteroviruses from an outbreak of hand, foot and mouth disease in Malaysia in 1997. Scand J Infect Dis 31: 331-335.
50. Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, et al. (1999) Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis 52: 12-15.
51. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, et al. (1999) An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enteroviurs Epidemic Working Group. N Engl J Med 341: 929-935.
52. Lu CY, Lee CY, Kao CL, Shao WY, Lee PI, et al. (2002) Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J Med Virol 67: 217-223.
53. Wang JR, Tuan YC, Tsai HP, Yan JJ, Liu CC, et al. (2002) Change of major genotype of enterovirus 71 in outbreaks of hand-foot and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol 40: 10-15.
54. Chu PY, Lin KH, Hwang KP, Chou LC, Wang CF, et al. (2001) Molecular epidemiology of enterovirus 71 in Taiwan. Arch Virol 146: 589-600.
55. Ahmad K, (2000) Hand, foot and mouth disease outbreak reported in Singapore. Lancet 356: 1338.
56. Ding NZ, Wang XM, Sun SW, Song Q, Li SN, et al. (2009) Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. Virus Res 145 (1): 157-161.
57. AbuBakar S, Sam IC, Yusof J, Lim MK, Misbah S, (2009) Enterovirus 71 outbreak, Brunei. Emerg Infect Dis 15: 79-82.
58. McMinn P, Stratov I, Nagarajan L, Davis S, (2001) Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 32: 236-242.
59. Alexander JP Jr, Baden L, Pallansch MA, Anderson LJ, (1994) Enterovirus 71 infections and neurologic disease-United States, 1977-1991. J Infect Dis 169: 905-908.
60. Kehle J, Roth B, Metzger C, Pfitzner A, Enders G, (2003) Molecular characterization of an Enterovirus 71 causing neurological disease in Germany. J Neurovirol 9: 126-128.
61. Verbruggen SC, Joostern KF, Castillo L, van Goudoever JB, (2007) Insulin therapy in the pediatric intensive care unit. Clin Nutr 26 (6): 677-690.
62. Huang YF, Chiu PC, Chen YY, Hsieh KS, Liu YC, et al. (2003) Cardiac troponin I: a reliable marker and early myocardial involvement with meningoencephalitis after fatal enterovirus-71 infection. J Infect 46 (4): 238-243.
63. Hsia SH, Wu CT, Chang JJ, Lin TY, Chung HT, et al. (2005) Predictors of unfavorable outcomes in enterovirus 71-related cardiopulmonary failure in children. Pediatr Infect Dis J 24 (4): 331-334.